3,5,3',5'-Tetrachloro-biphenyl-4,4'-diol

ID: ALA83116

Chembl Id: CHEMBL83116

Cas Number: 13049-13-3

PubChem CID: 97032

Max Phase: Preclinical

Molecular Formula: C12H6Cl4O2

Molecular Weight: 323.99

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Oc1c(Cl)cc(-c2cc(Cl)c(O)c(Cl)c2)cc1Cl

Standard InChI:  InChI=1S/C12H6Cl4O2/c13-7-1-5(2-8(14)11(7)17)6-3-9(15)12(18)10(16)4-6/h1-4,17-18H

Standard InChI Key:  YCYDXOVJXVALHY-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

THRA Tclin Thyroid hormone receptor (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TTR Tclin Transthyretin (2847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ttr Transthyretin (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 323.99Molecular Weight (Monoisotopic): 321.9122AlogP: 5.38#Rotatable Bonds: 1
Polar Surface Area: 40.46Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.11CX Basic pKa: CX LogP: 5.43CX LogD: 3.50
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.74Np Likeness Score: -0.10

References

1. Pedersen LG, Darden TA, Oatley SJ, McKinney JD..  (1986)  A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin.,  29  (12): [PMID:3097319] [10.1021/jm00162a006]
2. Rickenbacher U, McKinney JD, Oatley SJ, Blake CC..  (1986)  Structurally specific binding of halogenated biphenyls to thyroxine transport protein.,  29  (5): [PMID:3009810] [10.1021/jm00155a010]
3. McKinney J, Fannin R, Jordan S, Chae K, Rickenbacher U, Pedersen L..  (1987)  Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts.,  30  (1): [PMID:3100800] [10.1021/jm00384a014]
4. Lill MA, Winiger F, Vedani A, Ernst B..  (2005)  Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.,  48  (18): [PMID:16134935] [10.1021/jm050403f]
5. Cotrina EY, Pinto M, Bosch L, Vilà M, Blasi D, Quintana J, Centeno NB, Arsequell G, Planas A, Valencia G..  (2013)  Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.,  56  (22): [PMID:24147937] [10.1021/jm401061w]
6. Simões CJV, Almeida ZL, Costa D, Jesus CSH, Cardoso AL, Almeida MR, Saraiva MJ, Pinho E Melo TMVD, Brito RMM..  (2016)  A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition.,  121  [PMID:27020050] [10.1016/j.ejmech.2016.02.074]
7. Connelly S, Mortenson DE, Choi S, Wilson IA, Powers ET, Kelly JW, Johnson SM..  (2017)  Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.,  27  (15): [PMID:28625364] [10.1016/j.bmcl.2017.05.080]

Source